by admin | Dec 17, 2025 | Press release
WILMINGTON, Mass.–(BUSINESS WIRE)–Dec. 11, 2025– Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort...
by admin | Oct 10, 2025 | Press release
Development of Heart Muscle Regenerative Treatment for Ischemic Heart Disease San Diego, California Oct 6, 2025 (Issuewire.com) – Jaan Biotherapeutics, Inc., a privately held biopharmaceutical company based in San Diego, California, focused on developing novel...
by admin | Oct 10, 2024 | Press release
The Nobel Prize in Physiology or Medicine 2024 has been awarded to US scientists Victor Ambros and Gary Ruvkun for their work on microRNA. Their discoveries help explain how complex life emerged on Earth and how the human body is made up of a wide variety of...
by Bhawanjit Brar | Sep 12, 2024 | Press release
San Diego, California Sep 9, 2024 (Issuewire.com) – Jaan Biotherapeutics, a company developing microRNA targeting treatments for heart disease, the leading cause of death of both women and men in the United States of America, announced today that it was...
by admin | Oct 26, 2020 | Press release
JaanBiotherapeutics has been awarded the following NIH funded small business grants: 1R43HL154884-01 VIRAL DELIVERED CARDIAC REGENERATION 1R43HL137416-01A1 MicroRNA Inhibition for Cardiac Regeneration in Ischemia...
by admin | Oct 26, 2020 | Press release
PIPELINE HIGHLIGHTS Ischemic Heart Disease is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s potential. Development of Ischemic Heart Disease medicines is identified as integral to the strategy of...
